Multiparametric rapid test IHP-302

for antigensadenovirusRSV

Overview
HWTAI SARS-CoV-2 + Flu A/B + RSV + ADV Combo Rapid Test Kit is a lateral-flow colloidal-gold rapid antigen test for qualitative detection of SARS-CoV-2, Influenza A, Influenza B, Respiratory Syncytial Virus (RSV) and Adenovirus (ADV) antigens in human nasopharyngeal swab specimens. Visual results appear within 15 minutes and must not be interpreted after 20 minutes.

Comparison (COVID-19 / Influenza / RSV)

• SARS-CoV-2 • Etiology: SARS-CoV-2 virus; shares symptoms with influenza and can be more transmissible. • Typical symptoms: anosmia/ageusia, fever, chills, headache, cough, myalgia, fatigue, gastrointestinal symptoms, dyspnea, sore throat, rhinorrhea.
• Influenza (A/B) • Etiology: Seasonal influenza viruses; multiple strains circulate with seasonal peaks. • Typical symptoms: fever, chills, headache, cough, myalgia, fatigue, gastrointestinal symptoms, dyspnea, sore throat, rhinorrhea.
• RSV • Etiology: Respiratory syncytial virus; often causes mild, cold-like illness but can be severe in infants and high-risk adults. • Typical symptoms: fever, wheeze, cough, difficulty breathing in severe cases.

Features

• Multiplex detection of SARS-CoV-2, Influenza A, Influenza B, RSV (ADV detection included where applicable)
• Lateral-flow colloidal-gold immunoassay — visual readout, no instrument required
• Rapid time to result: read at 15 minutes; do not interpret after 20 minutes
• Single nasopharyngeal swab for multiple-target differentiation at point-of-care
• Suitable for rapid clinical screening and triage

Material provided

• Test cartridge(s)
• Sampling swab(s)
• Extraction tube(s)
• Extraction buffer sachet(s)
• Instructions for use

Operating steps (summary)

• Allow test device, specimen, buffer and controls to equilibrate to room temperature (15–30℃ / 59–86℉).
• Open pouch at room temperature and place device on a clean, level surface.
• Prepare specimen in extraction tube according to instructions and mix thoroughly.
• Hold dropper vertically; add 1 drop of processed specimen (approx. 10 µL) into the sample well, then add 2 drops of buffer (approx. 80 µL); start timer.
• Read results at 15 minutes. Do not interpret results after 20 minutes.

Product usage and application
Intended for use by healthcare professionals for point-of-care rapid screening and differentiation of respiratory infections caused by SARS-CoV-2, Influenza A/B and RSV (with ADV detection where included). Results support rapid clinical decision-making, patient triage and appropriate follow-up testing or treatment.

Technical specifications

• Targets: SARS-CoV-2, Influenza A, Influenza B, Respiratory Syncytial Virus (RSV), Adenovirus (ADV) — combo format
• Method: Lateral-flow colloidal-gold immunoassay
• Specimen type: Nasopharyngeal swab
• Time to result: Read at 15 minutes; do not interpret after 20 minutes
• Example kit size: 25 tests per kit (25T/Kit); packaging/variants may vary
• Storage & handling: Allow reagents and specimens to reach room temperature (15–30℃) before testing
• Equipment: Visual interpretation, no specialized instrument required
• Contents typically included: test cartridge, sampling swab, extraction tube, extraction buffer sachet, instructions for use